Sept. 11, 2024 — In the first national estimate in two decades, researchers at the University of California-San Francisco (UCSF) report that 10.5 million Americans have atrial fibrillation.

Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 million U.S. adults, according to new estimates from University of California-San Francisco.

Sept. 5, 2024 - Prolocor, Inc. and Slingshot Biosciences recently announced the publication in Bioanalysis of the results from their analytic validation testing titled: "Assessing Prognosis by Quantifying FcγRIIa on Fixed Platelets." 

Sept. 2, 2024 – Medtronic  recently shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and safety of the EV-ICD system. The results were presented at the ESC (European Society of Cardiology) Congress 2024 in London.

Sept. 1, 2024 — September is Peripheral Artery Disease (PAD) Awareness Month, a time to educate and empower people to act against the most debilitating disease they haven’t heard of — or know that they have.

Sept. 1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications.

The study was published in the American Journal of Human Genetics.

Aug. 28, 2024 — New research presented at this year’s ESC Congress 2024 in London, UK (Aug. 30 – Sept. 2) shows that performing echocardiograms remotely using a 5G cellular network has similar accuracy to those performed in person by cardiologists.  

“Comprehensive echocardiographic exam with a 5G cellular network and robotic arm-based remote system is feasible with relatively good diagnostic accuracy,” said study author Dr Yu Liu, Zhongshan Hospital, Shanghai, China.  

Aug. 22, 2024 – AISAP has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its first-of-a-kind, AI-powered AISAP CARDIO point-of-care ultrasound (POCUS) software platform.

Aug. 23, 2024 — A team led by researchers at Yale School of Medicine has created a deep learning model that can accurately project post-surgical outcomes for some patients with large vessel occlusion (LVO) stroke using computed tomography angiography (CTA) scans taken at admission. 

Subscribe Now